Suche

Person:

Zeige:

Publikationen

Zeige 1 bis 10 von 22 Ergebnissen

Footer

Betrieben von

Universität Münster
Abteilung 6.4: Forschungsinformationen & Forschungsberichterstattung
Domplatz 6-7 | 48143 Münster
cris@uni-muenster.de

Top-Links

Über die Universität Münster
Forschungsprofil der Universität Münster
CRIS-Login

wissen.leben

Impressum | Datenschutz | Barrierefreiheit

Suche

Markov, Arseni

Zeige 1 bis 10 von 22 Ergebnissen

Lessons from the EThIGII Trial: Proper Putative Benefit Assessment of Low-Molecular-Weight Heparin Treatment in M2/ANXA5 Haplotype Carriers Rogenhofer N., Markoff A., Wagner A., Klein H., Petroff D., Schleussner E., Thaler C. (2017) In: Clinical and Applied Thrombosis/Hemostasis, 23(1), 27-33. doi:10.1177/1076029616658117 Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
Genetic analysis of the M2/ANXA5 haplotype as recurrent pregnancy loss predisposition in the Malay population Ang K., Kathirgamanathan S., Ch’ng E., Lee Y., Roslani A., Naidu B., Kumar K., Abdullah R., Kadir S., Yusoff N., Abdullah W., Bogdanova N., Wieacker P., Markoff A., Tang T. (2017) In: Journal of Assisted Reproduction and Genetics, null(null), 1-8. doi:10.1007/s10815-017-0871-0 Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
Authors' response to the letter of Nagirnaja et al., “Response to annexin A5 haplotype M2 is not a risk factor for recurrent miscarriages in Northern Europe, is there sufficient evidence?” Markoff A., Kurahashi H., Grandone E., Bogdanova N. (2016) In: Reproductive BioMedicine Online, 33(1), 116-117. doi:10.1016/j.rbmo.2016.05.006 Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
Lessons From the EThIGII Trial: Proper Putative Benefit Assessment of Low- Molecular-Weight Heparin Treatment in M2/ANXA5 Haplotype Carriers Rogenhofer N, Markoff A, Wagner A, Klein HG, Petroff D, Schleussner E, Thaler CJ (2016) In: Clinical and Applied Thrombosis/Hemostasis, 2016. doi:10.1177/1076029616658117 Forschungsartikel (Zeitschrift) \| Peer reviewed \| online first
Annexin A5 haplotype M2 is not a risk factor for recurrent spontaneous abortion in Northern Europe: Is there sufficient evidence? Markoff A., Kurahashi H., Grandone E., Bogdanova N. (2016) In: Reproductive BioMedicine Online, null(null). doi:10.1016/j.rbmo.2016.02.004 Forschungsartikel (Zeitschrift) \| Peer reviewed \| online first
M2/ANXA5 haplotype as a predisposition factor in Malay women and couples experiencing recurrent spontaneous abortion: A pilot study In: , -. \| Peer reviewed
Investigation of the Annexin A5 M2 haplotype in 500 white European couples who have experienced recurrent spontaneous abortion In: , -. \| Peer reviewed
Lower incidence of M2/ANXA5 carriage in recurrent pregnancy loss patients with elevated lipoprotein(a) levels In: , -. \| Peer reviewed
Further insights into the role of the annexin A5 M2 haplotype as recurrent pregnancy loss factor, assessing timing of miscarriage and partner risk In: , -. \| Peer reviewed
The haplotype M2 of the ANXA5 gene is not associated with antitrophoblast antibodies In: , -. \| Peer reviewed

Thean Hock T., Bogdanova N., Kai Cheen A., Kathirgamanathan S., Bin Abdullah R., Mohd Yusoff N., Zaidah Abdullah W., Syima Abdul Manaf F., Wieacker P., Markoff A.

(2015)

Reproductive BioMedicine Online

, 30

(4)

434

439

doi:10.1016/j.rbmo.2014.12.014

Forschungsartikel (Zeitschrift)

| Veröffentlicht

Demetriou C., Abu-Amero S., White S., Peskett E., Markoff A., Stanier P., Moore G., Regan L.

(2015)

Reproductive BioMedicine Online

, 31

(5)

681

688

doi:10.1016/j.rbmo.2015.07.004

Forschungsartikel (Zeitschrift)

| Veröffentlicht

Rogenhofer N., Engels L., Bogdanova N., Tüttelmann F., Thaler C., Markoff A.

(2014)

Clinical and Applied Thrombosis/Hemostasis

, 20

(7)

706

709

doi:10.1177/1076029613516189

Forschungsartikel (Zeitschrift)

| Veröffentlicht

Tüttelmann F., Ivanov P., Dietzel C., Sofroniou A., Tsvyatkovska T., Komsa-Penkova R., Markoff A., Wieacker P., Bogdanova N.

(2013)

Fertility and Sterility

, 100

(5)

1321

1325

doi:10.1016/j.fertnstert.2013.06.046

Forschungsartikel (Zeitschrift)

| Veröffentlicht

Rogenhofer N., Engels L., Bogdanova N., Tüttelmann F., Markoff A., Thaler C.

(2013)

Journal of Assisted Reproduction and Genetics

, 30

(5)

711

716

doi:10.1007/s10815-013-9978-0

Forschungsartikel (Zeitschrift)

| Veröffentlicht

Lessons from the EThIGII Trial: Proper Putative Benefit Assessment of Low-Molecular-Weight Heparin Treatment in M2/ANXA5 Haplotype Carriers Rogenhofer N., Markoff A., Wagner A., Klein H., Petroff D., Schleussner E., Thaler C. (2017) In: Clinical and Applied Thrombosis/Hemostasis, 23(1), 27-33. doi:10.1177/1076029616658117 Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
Genetic analysis of the M2/ANXA5 haplotype as recurrent pregnancy loss predisposition in the Malay population Ang K., Kathirgamanathan S., Ch’ng E., Lee Y., Roslani A., Naidu B., Kumar K., Abdullah R., Kadir S., Yusoff N., Abdullah W., Bogdanova N., Wieacker P., Markoff A., Tang T. (2017) In: Journal of Assisted Reproduction and Genetics, null(null), 1-8. doi:10.1007/s10815-017-0871-0 Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
Authors' response to the letter of Nagirnaja et al., “Response to annexin A5 haplotype M2 is not a risk factor for recurrent miscarriages in Northern Europe, is there sufficient evidence?” Markoff A., Kurahashi H., Grandone E., Bogdanova N. (2016) In: Reproductive BioMedicine Online, 33(1), 116-117. doi:10.1016/j.rbmo.2016.05.006 Forschungsartikel (Zeitschrift) \| Peer reviewed \| Veröffentlicht
Lessons From the EThIGII Trial: Proper Putative Benefit Assessment of Low- Molecular-Weight Heparin Treatment in M2/ANXA5 Haplotype Carriers Rogenhofer N, Markoff A, Wagner A, Klein HG, Petroff D, Schleussner E, Thaler CJ (2016) In: Clinical and Applied Thrombosis/Hemostasis, 2016. doi:10.1177/1076029616658117 Forschungsartikel (Zeitschrift) \| Peer reviewed \| online first
Annexin A5 haplotype M2 is not a risk factor for recurrent spontaneous abortion in Northern Europe: Is there sufficient evidence? Markoff A., Kurahashi H., Grandone E., Bogdanova N. (2016) In: Reproductive BioMedicine Online, null(null). doi:10.1016/j.rbmo.2016.02.004 Forschungsartikel (Zeitschrift) \| Peer reviewed \| online first
M2/ANXA5 haplotype as a predisposition factor in Malay women and couples experiencing recurrent spontaneous abortion: A pilot study In: , -. \| Peer reviewed
Investigation of the Annexin A5 M2 haplotype in 500 white European couples who have experienced recurrent spontaneous abortion In: , -. \| Peer reviewed
Lower incidence of M2/ANXA5 carriage in recurrent pregnancy loss patients with elevated lipoprotein(a) levels In: , -. \| Peer reviewed
Further insights into the role of the annexin A5 M2 haplotype as recurrent pregnancy loss factor, assessing timing of miscarriage and partner risk In: , -. \| Peer reviewed
The haplotype M2 of the ANXA5 gene is not associated with antitrophoblast antibodies In: , -. \| Peer reviewed